Agilent Technologies Inc
A157.200USD
+3.600+2.34%
종가 11/25, 16:00（ET）시세는 15분 지연됩니다
44.58B시가총액
36.54P/E TTM
자세한 내용은 Agilent Technologies Inc 회사
Agilent Technologies, Inc. is engaged in providing application focused solutions that include instruments, software, services and consumables for the entire laboratory workflow. The Company’s life sciences and applied markets segment provides application-focused solutions that include instruments, consumables and software that enable customers to identify, quantify and analyze the physical and biological properties of substances and products. Its diagnostics and genomics segment includes the cell analysis, advanced manufacturing partnerships contract manufacturing and research and development, pathology, companion diagnostics, reagent partnership, genomics and biomolecular analysis businesses. The Agilent CrossLab segment offers a service portfolio that includes repairs, parts, maintenance, installations and various other custom services to support the laboratory operations. It also offers contract development and manufacturing organization (CDMO) services.
Agilent Technologies Inc 정보
종목 코드 A
회사 이름Agilent Technologies Inc
상장일Nov 18, 1999
CEOMr. Padraig Mcdonnell
직원 수17900
유형Ordinary Share
회계 연도 종료Nov 18
주소5301 Stevens Creek Blvd
도시SANTA CLARA
증권 거래소NYSE Consolidated
국가United States of America
우편 번호95051
전화14083458886
웹사이트https://www.agilent.com/
종목 코드 A
상장일Nov 18, 1999
CEOMr. Padraig Mcdonnell
Agilent Technologies Inc의 회사 임원진
이름
이름/직위
직위
주식 보유
변동
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.55K
+2.11%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Vice President, Corporate Controller, Principal Accounting Officer
Vice President, Corporate Controller, Principal Accounting Officer
52.33K
+8.01%
Mr. Padraig Mcdonnell
Mr. Padraig Mcdonnell
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
41.84K
+568.28%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.35K
+4.98%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.68K
--
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.04K
+11.21%
Ms. Mala Anand
Ms. Mala Anand
Independent Director
Independent Director
14.55K
+14.29%
Dr. Simon May
Dr. Simon May
Senior Vice President, Agilent President, Life Sciences and Diagnostics Markets Group
Senior Vice President, Agilent President, Life Sciences and Diagnostics Markets Group
14.10K
+92.65%
Mr. Bret M. Dimarco
Mr. Bret M. Dimarco
Senior Vice President, Chief Legal Officer, Secretary
Senior Vice President, Chief Legal Officer, Secretary
12.21K
+130.83%
Mr. Adam Stewart Elinoff
Mr. Adam Stewart Elinoff
Chief Financial Officer, Senior Vice President
Chief Financial Officer, Senior Vice President
11.73K
--
더 보기
이름
이름/직위
직위
주식 보유
변동
Mr. Boon Hwee Koh
Mr. Boon Hwee Koh
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
61.55K
+2.11%
Mr. Rodney Gonsalves
Mr. Rodney Gonsalves
Vice President, Corporate Controller, Principal Accounting Officer
Vice President, Corporate Controller, Principal Accounting Officer
52.33K
+8.01%
Mr. Padraig Mcdonnell
Mr. Padraig Mcdonnell
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
41.84K
+568.28%
Dr. George A. Scangos, Ph.D.
Dr. George A. Scangos, Ph.D.
Independent Director
Independent Director
38.35K
+4.98%
Dr. Daniel K. Podolsky, M.D.
Dr. Daniel K. Podolsky, M.D.
Independent Director
Independent Director
35.68K
--
Mr. Dow R. Wilson
Mr. Dow R. Wilson
Independent Director
Independent Director
18.04K
+11.21%
수익 분석
통화: USD마지막 업데이트: Mon, Oct 6
통화: USD마지막 업데이트: Mon, Oct 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2021
FY2020
FY2019
FY2018
사업별USD
이름
수익
비율
Non-instrumentation and other
1.14B
65.54%
Instrumentation
599.00M
34.46%
지역별USD
이름
수익
비율
United States
683.00M
39.30%
Asia Pacific
563.00M
32.39%
Europe
492.00M
28.31%
사업별
지역별
사업별USD
이름
수익
비율
Non-instrumentation and other
1.14B
65.54%
Instrumentation
599.00M
34.46%
주식 보유 통계
마지막 업데이트: Sun, Nov 16
마지막 업데이트: Sun, Nov 16
주주
주주 유형
주주
주주
비율
The Vanguard Group, Inc.
11.96%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.39%
MFS Investment Management
4.06%
Wellington Management Company, LLP
3.31%
기타
71.01%
주주
주주
비율
The Vanguard Group, Inc.
11.96%
BlackRock Institutional Trust Company, N.A.
5.27%
State Street Investment Management (US)
4.39%
MFS Investment Management
4.06%
Wellington Management Company, LLP
3.31%
기타
71.01%
주주 유형
주주
비율
Investment Advisor
44.00%
Investment Advisor/Hedge Fund
37.16%
Hedge Fund
3.09%
Pension Fund
1.84%
Insurance Company
1.67%
Research Firm
1.61%
Bank and Trust
1.43%
Sovereign Wealth Fund
1.23%
Family Office
0.44%
기타
7.54%
기관 주식 보유
마지막 업데이트: Wed, Oct 1
마지막 업데이트: Wed, Oct 1
보고 기간
기관 수
보유 주식
비율
변동
2025Q3
2069
259.89M
91.67%
-7.58M
2025Q2
2111
262.65M
92.46%
-3.65M
2025Q1
2174
262.93M
92.55%
-7.77M
2024Q4
2144
261.66M
91.77%
-9.44M
2024Q3
2092
261.54M
91.00%
-12.94M
2024Q2
2065
263.61M
90.36%
-18.36M
2024Q1
2066
270.62M
92.35%
-9.44M
2023Q4
2084
269.59M
92.01%
-3.30M
2023Q3
2017
262.63M
89.76%
-13.56M
2023Q2
2002
268.16M
90.78%
-20.64M
더 보기
주주 활동
이름
보유 주식
비율
변동
Chg %
날짜
The Vanguard Group, Inc.
33.87M
11.95%
+586.53K
+1.76%
Jun 30, 2025
BlackRock Institutional Trust Company, N.A.
14.86M
5.24%
-507.73K
-3.30%
Jun 30, 2025
State Street Investment Management (US)
12.45M
4.39%
-155.76K
-1.24%
Jun 30, 2025
MFS Investment Management
12.19M
4.3%
+1.21M
+11.01%
Jun 30, 2025
Wellington Management Company, LLP
8.95M
3.16%
+16.40K
+0.18%
Jun 30, 2025
T. Rowe Price Investment Management, Inc.
8.16M
2.88%
+562.40K
+7.40%
Jun 30, 2025
Geode Capital Management, L.L.C.
7.32M
2.58%
+115.18K
+1.60%
Jun 30, 2025
Generation Investment Management LLP
5.78M
2.04%
+792.30K
+15.90%
Jun 30, 2025
Pictet Asset Management Ltd.
4.77M
1.68%
-569.04K
-10.65%
Jun 30, 2025
DWS Investment GmbH
3.81M
1.34%
+820.80K
+27.49%
Jun 30, 2025
더 보기
관련 ETF
마지막 업데이트: Thu, Nov 6
마지막 업데이트: Thu, Nov 6
이름
비율
Honeytree US Equity ETF
4.44%
First Trust Water ETF
4.14%
Goldman Sachs Future Health Care Equity ETF
3.08%
VanEck Morningstar Wide Moat Value ETF
2.89%
Madison Covered Call ETF
2.88%
VanEck Morningstar Wide Moat ETF
2.56%
First Trust Indxx Medical Devices ETF
2.4%
Argent Mid Cap ETF
2.19%
Global X Genomics & Biotechnology ETF
2.17%
iShares Health Innovation Active ETF
2.03%
더 보기
Honeytree US Equity ETF
비율4.44%
First Trust Water ETF
비율4.14%
Goldman Sachs Future Health Care Equity ETF
비율3.08%
VanEck Morningstar Wide Moat Value ETF
비율2.89%
Madison Covered Call ETF
비율2.88%
VanEck Morningstar Wide Moat ETF
비율2.56%
First Trust Indxx Medical Devices ETF
비율2.4%
Argent Mid Cap ETF
비율2.19%
Global X Genomics & Biotechnology ETF
비율2.17%
iShares Health Innovation Active ETF
비율2.03%
주식 배당금
지난 5년 동안 총
1.31B
USD의 배당금이 분배되었습니다.
날짜
배당금
기준일
지급일
배당락일
Nov 20, 2024
A.NB Interim Cash Dividend of gross USD 0.248 paid on Jan 22, 2025 going ex on Dec 31, 2024 with reinvestment option
Dec 31, 2024
Jan 22, 2025
Dec 31, 2024
Sep 18, 2024
A.NB Final Cash Dividend of gross USD 0.236 paid on Oct 23, 2024 going ex on Oct 01, 2024 with reinvestment option
Oct 01, 2024
Oct 23, 2024
Oct 01, 2024
May 22, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jul 24, 2024 going ex on Jul 02, 2024
Jul 02, 2024
Jul 24, 2024
Jul 02, 2024
Feb 21, 2024
A.NB Interim Cash Dividend of gross USD 0.236 paid on Apr 24, 2024 going ex on Apr 01, 2024
Apr 02, 2024
Apr 24, 2024
Apr 01, 2024
Nov 16, 2023
A.NB Interim Cash Dividend of gross USD 0.236 paid on Jan 24, 2024 going ex on Dec 29, 2023
Jan 02, 2024
Jan 24, 2024
Dec 29, 2023
Sep 21, 2023
A.NB Final Cash Dividend of gross USD 0.225 paid on Oct 25, 2023 going ex on Oct 02, 2023 with reinvestment option
Oct 03, 2023
Oct 25, 2023
Oct 02, 2023
May 18, 2023
A.NB Interim Cash Dividend of gross USD 0.225 paid on Jul 26, 2023 going ex on Jun 30, 2023 with reinvestment option
Jul 03, 2023
Jul 26, 2023
Jun 30, 2023
Feb 22, 2023
A.NB Interim Cash Dividend of gross USD 0.225 paid on Apr 26, 2023 going ex on Apr 03, 2023
Apr 04, 2023
Apr 26, 2023
Apr 03, 2023
Nov 16, 2022
A.NB Interim Cash Dividend of gross USD 0.225 paid on Jan 25, 2023 going ex on Dec 30, 2022
Jan 03, 2023
Jan 25, 2023
Dec 30, 2022
Sep 21, 2022
A.NB Final Cash Dividend of gross USD 0.21 paid on Oct 26, 2022 going ex on Oct 03, 2022
Oct 04, 2022
Oct 26, 2022
Oct 03, 2022
더 보기
주식 분할
날짜
유형
비율
데이터 없음
날짜
유형
비율
데이터 없음
자주 묻는 질문
Agilent Technologies Inc의 상위 5대 주주는 누구인가요?
Agilent Technologies Inc의 상위 5대 주주는 다음과 같습니다:
The Vanguard Group, Inc.는 33.87M주의 주식을 보유하고 있으며, 전체 주식의 11.95%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 14.86M주의 주식을 보유하고 있으며, 전체 주식의 5.24%를 차지합니다.
State Street Investment Management (US)는 12.45M주의 주식을 보유하고 있으며, 전체 주식의 4.39%를 차지합니다.
MFS Investment Management는 12.19M주의 주식을 보유하고 있으며, 전체 주식의 4.30%를 차지합니다.
Wellington Management Company, LLP는 8.95M주의 주식을 보유하고 있으며, 전체 주식의 3.16%를 차지합니다.
The Vanguard Group, Inc.는 33.87M주의 주식을 보유하고 있으며, 전체 주식의 11.95%를 차지합니다.
BlackRock Institutional Trust Company, N.A.는 14.86M주의 주식을 보유하고 있으며, 전체 주식의 5.24%를 차지합니다.
State Street Investment Management (US)는 12.45M주의 주식을 보유하고 있으며, 전체 주식의 4.39%를 차지합니다.
MFS Investment Management는 12.19M주의 주식을 보유하고 있으며, 전체 주식의 4.30%를 차지합니다.
Wellington Management Company, LLP는 8.95M주의 주식을 보유하고 있으며, 전체 주식의 3.16%를 차지합니다.
Agilent Technologies Inc의 상위 3대 주주 유형은 무엇인가요?
Agilent Technologies Inc의 주요 주주 유형 상위 3가지는
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)입니다.
The Vanguard Group, Inc.
BlackRock Institutional Trust Company, N.A.
State Street Investment Management (US)입니다.
Agilent Technologies Inc(A)의 주식을 보유한 기관은 몇 개입니까?
2025Q3 기준으로, Agilent Technologies Inc의 주식을 보유한 기관은 총 2069곳이며, 이들이 보유한 주식의 총 가치는 약 259.89M로 전체 발행 주식의 91.67%를 차지합니다. 이는 2025Q2 대비 -0.79% 증가한 수치입니다.
Agilent Technologies Inc의 최대 수익원은 무엇인가요?
FY2025Q3 기준, Agilent Technologies Inc의 Non-instrumentation and other 부문이 가장 높은 매출을 기록했으며, 금액은 1.14B로 전체 매출의 65.54%를 차지했습니다.
